272 related articles for article (PubMed ID: 31825688)
1. Chemotherapy-induced mucositis development in a murine model of colitis-associated colorectal cancer.
Chartier LC; Howarth GS; Mashtoub S
Scand J Gastroenterol; 2020 Jan; 55(1):47-54. PubMed ID: 31825688
[No Abstract] [Full Text] [Related]
2. Emu Oil and Saireito in combination reduce tumour development and clinical indicators of disease in a mouse model of colitis-associated colorectal cancer.
Chartier LC; Fujino J; Howarth GS; Freysdottir J; Hardardottir I; Mashtoub S
Biomed Pharmacother; 2021 Jun; 138():111478. PubMed ID: 33756155
[TBL] [Abstract][Full Text] [Related]
3. Emu oil and grape seed extract reduce tumour burden and disease parameters in murine colitis-associated colorectal cancer.
Chartier LC; Howarth GS; Trinder D; Mashtoub S
Carcinogenesis; 2021 Feb; 42(2):202-209. PubMed ID: 32940671
[TBL] [Abstract][Full Text] [Related]
4. Emu Oil Attenuates Disease Severity and Results in Fewer Large Colonic Tumors in a Mouse Model of Colitis-Associated Colorectal Cancer.
Mashtoub S; Chartier LC; Trinder D; Lawrance IC; Howarth GS
Nutr Cancer; 2022; 74(2):715-723. PubMed ID: 33840308
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin Liposomes Combined with 5-Fluorouracil Inhibits Angiogenesis and Tumor Growth of APC
Liu XM; Zhu WT; Jia ML; Li YT; Hong Y; Liu ZQ; Yan PK
Int J Nanomedicine; 2022; 17():5049-5061. PubMed ID: 36325149
[TBL] [Abstract][Full Text] [Related]
6. The germ-free mice monocolonization with
Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
[No Abstract] [Full Text] [Related]
7. Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS).
Thaker AI; Shaker A; Rao MS; Ciorba MA
J Vis Exp; 2012 Sep; (67):. PubMed ID: 22990604
[TBL] [Abstract][Full Text] [Related]
8. Effects of 17β-estradiol on colorectal cancer development after azoxymethane/dextran sulfate sodium treatment of ovariectomized mice.
Song CH; Kim N; Lee SM; Nam RH; Choi SI; Kang SR; Shin E; Lee DH; Lee HN; Surh YJ
Biochem Pharmacol; 2019 Jun; 164():139-151. PubMed ID: 30981879
[TBL] [Abstract][Full Text] [Related]
9. Affective state determination in a mouse model of colitis-associated colorectal cancer.
Chartier LC; Hebart ML; Howarth GS; Whittaker AL; Mashtoub S
PLoS One; 2020; 15(1):e0228413. PubMed ID: 31986185
[TBL] [Abstract][Full Text] [Related]
10. Emu Oil reduces disease severity in a mouse model of chronic ulcerative colitis.
Safaeian R; Howarth GS; Lawrance IC; Trinder D; Mashtoub S
Scand J Gastroenterol; 2019 Mar; 54(3):273-280. PubMed ID: 30907169
[No Abstract] [Full Text] [Related]
11. The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer.
Angelou A; Papalois AE; Antoniou E; Wang J; Amini N; Pikouli A; Andreatos N; Buettner S; Munir M; Theodoropoulos G; Zografos GC; Sarantis P; Pulvirenti A; Kamphues C; Theocharis S; Pikoulis E; Margonis GA
Anticancer Res; 2020 Oct; 40(10):5457-5462. PubMed ID: 32988867
[TBL] [Abstract][Full Text] [Related]
12. Aqueous extracts of Ocimum gratissimum mitigate colitis and protect against AOM/DSS-induced colorectal cancer in mice.
Liu JY; Tsai FL; Chuang YL; Ye JC
Carcinogenesis; 2023 Dec; 44(12):837-846. PubMed ID: 37864831
[TBL] [Abstract][Full Text] [Related]
13. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
[TBL] [Abstract][Full Text] [Related]
14. Differences in colonic crypt morphology of spontaneous and colitis-associated murine models via second harmonic generation imaging to quantify colon cancer development.
Prieto SP; Reed CL; James HM; Quinn KP; Muldoon TJ
BMC Cancer; 2019 May; 19(1):428. PubMed ID: 31072353
[TBL] [Abstract][Full Text] [Related]
15. 5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.
Clapper ML; Gary MA; Coudry RA; Litwin S; Chang WC; Devarajan K; Lubet RA; Cooper HS
Inflamm Bowel Dis; 2008 Oct; 14(10):1341-7. PubMed ID: 18452197
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of PD-1 follows tumour development in the AOM/DSS model of inflammation-induced colorectal cancer in mice.
Yassin M; Sadowska Z; Djurhuus D; Nielsen B; Tougaard P; Olsen J; Pedersen AE
Immunology; 2019 Sep; 158(1):35-46. PubMed ID: 31429085
[TBL] [Abstract][Full Text] [Related]
17. Enterotoxigenic
Hwang S; Lee CG; Jo M; Park CO; Gwon SY; Hwang S; Yi HC; Lee SY; Eom YB; Karim B; Rhee KJ
Int J Med Sci; 2020; 17(2):145-152. PubMed ID: 32038097
[TBL] [Abstract][Full Text] [Related]
18. AOM/DSS Induced Colitis-Associated Colorectal Cancer in 14-Month-Old Female Balb/C and C57/Bl6 Mice-A Pilot Study.
Schepelmann M; Kupper N; Gushchina V; Mesteri I; Manhardt T; Moritsch S; Müller C; Piatek K; Salzmann M; Vlasaty A; Eferl R; Kallay E
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563665
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation.
Liu L; Gao H; Wen T; Gu T; Zhang S; Yuan Z
Pharm Biol; 2021 Dec; 59(1):89-96. PubMed ID: 33535870
[TBL] [Abstract][Full Text] [Related]
20. AOM/DSS Model of Colitis-Associated Cancer.
Parang B; Barrett CW; Williams CS
Methods Mol Biol; 2016; 1422():297-307. PubMed ID: 27246042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
